AnPac Bio-Medical Science Co., Ltd. announced that the Company's Members approved Written Resolutions of a Majority of the Members (the “Resolutions”) on July 14, 2022 addressing the removal of directors and officers, re-designation of officers, and change of members of the committees. The Resolutions were approved by 69.29% of the total voting power of the Company entitled to vote at a general meeting in accordance with British Virgin Islands law, which allows Member's resolutions to be approved by written resolutions signed by a majority of the votes of all Members entitled to vote on the resolution at a general meeting. The proposals authorized the removal of Aidong Chen and Sheng Liu as Directors, the removal of Aidong Chen as (a) Co-Chairman of the Board of Directors of the Company effective immediately without compensation for loss of office; (2) the re-designation of Chris Chang Yu as Chairman of the Board, approved with immediate effect; (3) the removal of Sheng Liu as the chairman of the Nomination Committee of the Board and as a member of the Compensation Committee of the Board, effective immediately, and (4) the appointment of Chris Chang Yu as the chairman of the Nomination Committee of the Board and as a member of the Compensation Committee of the Board.